The Pediatric Infectious Disease Journal · 2011 · 41 citations · 6 references
PharmacyPediatricsToxicologyMitochondrial BiologyPediatric Clinical PharmacologyPharmaceutical ToxicologyAcid-base DisordersMitochondrial DysfunctionMitochondrial ToxicityLactic AcidosisMitochondrial Protein Synthesis InhibitionMitochondrial Protein Synthesis Regulation
Linezolid administration has been associated with lactic acidosis in adults; however, the same phenomenon has not been reported in children. Mitochondrial protein synthesis inhibition is a demonstrated mechanism for toxicity, which therefore may manifest as lactic acidosis. Three cases of linezolid-associated lactic acidosis in children are reported to reinforce the need for pediatric caregivers to be vigilant of this potential side effect.
6
Linezolid-Induced Inhibition of Mitochondrial Protein Synthesis
An S. De Vriese, Rudy Van Coster, Joél Smet et al. · Clinical Infectious Diseases · 2006 · 318 citations
Nele Plock, Cornelia Buerger, Christian Joukhadar et al. · Drug Metabolism and Disposition · 2007 · 84 citations